Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Mårten Sundberg, Jonas Bergquist, Margareta Ramström
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Pig proteomics: a review of a species in the crossroad between biomedical and food sciences
10.1016/j.jprot.2012.04.010 · 2012
Proteomics, a new tool for farm animal science
10.1016/j.jprot.2012.05.014 · 2012
Proteomics of rat biological fluids – the tenth anniversary update
10.1016/j.jprot.2012.03.053 · 2012
Neglected markers: altered serum proteome in murine models of disease
10.1002/pmic.201100320 · 2012
Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis
10.1016/j.jchromb.2006.11.051 · 2007
Mass spectrometry and animal science: protein identification strategies and particularities of farm animal species
10.1016/j.jprot.2012.04.009 · 2012
Farm animal proteomics – a review
10.1016/j.jprot.2010.11.005 · 2011
BACE1 inhibition induces a specific cerebrospinal fluid beta-amyloid pattern that identifies drug effects in the central nervous system
10.1371/journal.pone.0031084 · 2012
Evaluation of the performance of novel Abeta isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient
10.1159/000334537 · 2012
Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis
10.1021/pr201244t · 2012
A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid
10.1021/pr070247w · 2007
Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid
10.1042/bj20030059 · 2003
Proteins released from degenerating neurons are surrogate markers for acute brain damage
10.1016/j.nbd.2004.03.016 · 2004
Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia
10.1016/j.molbrainres.2004.06.021 · 2004
A comprehensive proteome map of bovine cerebrospinal fluid
10.1002/pmic.200800906 · 2009
Establishing the proteome of normal human cerebrospinal fluid
10.1371/journal.pone.0010980 · 2010
A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry
10.1002/pmic.200600756 · 2007
In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
10.1074/mcp.m114.038554 · 2014
Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome
10.1371/journal.pone.0017287 · 2011
Gray matter is targeted in first-attack multiple sclerosis
10.1371/journal.pone.0066117 · 2013
Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry
10.1021/pr300785h · 2013
Characterization of individual mouse cerebrospinal fluid proteomes
10.1002/pmic.201300241 · 2014
Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison
10.1002/1522-2683(200108)22:14<3043::aid-elps3043>3.0.co;2-m · 2001
Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008
10.1016/j.tvjl.2009.03.031 · 2010
Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsy
10.1371/journal.pone.0106026 · 2014
Canine astrocytic tumors: a comparative review
10.1177/0300985810389543 · 2011
The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches
10.3233/jad-2008-15413 · 2008
A canine model of human aging and Alzheimer's disease
1832
Animal models of Alzheimer's disease: therapeutic implications
10.3233/jad-2008-15401 · 2008
Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy
10.1371/journal.pone.0048478 · 2012
Gene therapy of the brain in the dog model of Hurler's syndrome
10.1002/ana.20870 · 2006
Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes
2011
Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment
10.1021/pr070220c · 2007
Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis
10.1021/pr070293w · 2007
Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges
10.1155/2006/158797 · 2006
Proteomics analysis of prefractionated human lumbar cerebrospinal fluid
10.1002/pmic.200400934 · 2005
Affinity separation and enrichment methods in proteomic analysis
10.1016/j.jprot.2008.06.011 · 2008
Protein and peptide fractionation, enrichment and depletion: tools for the complex proteome
10.1002/pmic.201000394 · 2011
Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis – an update covering the period 2008–2011
10.1002/elps.201100431 · 2012
Depletion of one, six, 12 or 20 major blood proteins before proteomic analysis: the more the better?
10.1016/j.jprot.2009.03.008 · 2009
Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment
10.1021/pr0503681 · doi-reference
Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease
10.1074/mcp.m800231-mcp200 · doi-reference
Differences among techniques for high-abundant protein depletion
10.1002/pmic.200402021 · doi-reference
High-abundance protein depletion: comparison of methods for human plasma biomarker discovery
10.1002/elps.200900286 · doi-reference
Removal of albumin and immunoglobulins from canine cerebrospinal fluid using depletion kits: a feasibility study
10.1186/2045-8118-11-14 · doi-reference
Role of spectral counting in quantitative proteomics
10.1586/epr.09.69 · doi-reference
A model for random sampling and estimation of relative protein abundance in shotgun proteomics
10.1021/ac0498563 · doi-reference
Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells
10.1097/cad.0000000000000069 · doi-reference
Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid
10.1007/s00216-014-8058-3 · doi-reference
Cerebrospinal fluid inflammatory cytokines and chemokines in naturally-occurring canine spinal cord injury
10.1089/neu.2014.3405 · doi-reference
A protocol for the management of canine cerebrospinal fluid for the proteomic assessment of putative biomarkers
10.1016/j.tvjl.2013.05.039 · doi-reference
Quantitative assessment of hsp70, IL-1beta and TNF-alpha in the spinal cord of dogs with E40K SOD1-associated degenerative myelopathy
10.1016/j.tvjl.2014.03.003 · doi-reference
Proteome analysis of cerebrospinal fluid in healthy beagles and canine encephalitis
10.1292/jvms.11-0474 · doi-reference
In between – proteomics of dog biological fluids
10.1016/j.jprot.2014.04.016 · doi-reference
Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers
10.1016/j.jchromb.2010.05.036 · doi-reference
In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification
10.1074/mcp.m900513-mcp200 · doi-reference
Assessment of the partitioning capacity of high abundant proteins in human cerebrospinal fluid using affinity and immunoaffinity subtraction spin columns
10.1016/j.jchromb.2010.04.003 · doi-reference
Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid
10.1042/ba20080015 · doi-reference
A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid
10.1002/pmic.201200192 · doi-reference